VitaNova Life Sciences (VNOV) EBITDA Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly EBITDA Margin came in at 6.15% in Q2 2026, down 6156.0% YoY from 0.1% in Q2 2025, and down 193.47% on a QoQ basis from 6.59% in Q1 2026.
VitaNova Life Sciences (VNOV) EBITDA Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 7 years of EBITDA Margin data on file, last reported at 6.15% in Q2 2026.
- Quarterly EBITDA Margin fell 6156.0% year-over-year to 6.15% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.12% (down 4527.0% YoY) and the FY2026 annual result came in at 0.12%, down 4527.0% from the prior year.
- EBITDA Margin fell to 6.15% in Q2 2026, from 6.59% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 80.74% in Q1 2022 to a low of 176.03% in Q1 2023.
- A 5-year average of 7.15% and a median of 17.83% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin slumped 25677 bps — and 2024, when it surged 19882 bps.
- Tracing VNOV's EBITDA Margin over 5 years: stood at 44.14% in 2022, then slumped by 431 bps to 146.17% in 2023, then jumped by 115 bps to 21.43% in 2024, then rose by 8 bps to 23.22% in 2025, then tumbled by 127 bps to 6.15% in 2026.
- The last three EBITDA Margin figures came in at 6.15% (Q2 2026), 6.59% (Q1 2026), and 23.22% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.50% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -0.84% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -14.82% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -6.15% |
| Jan 31, 2026 | 6.59% |
| Oct 31, 2025 | 23.22% |
| Jul 31, 2025 | -31.22% |
| Apr 30, 2025 | 55.41% |
| Jan 31, 2025 | 35.31% |
| Oct 31, 2024 | 21.43% |
| Jul 31, 2024 | -41.87% |
| Apr 30, 2024 | 42.73% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -176.03% |
| Oct 31, 2022 | 44.14% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | -59.57% |
| Jan 31, 2022 | 80.74% |
| Oct 31, 2021 | -66.65% |
| Jul 31, 2017 | 116.47% |